-
1
-
-
0037451929
-
The epidemiology of sepsis in the United States from 1979 through 2000
-
Martin GS, Mannino DM, Eaton S et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
-
(2003)
N Engl J Med
, vol.348
, pp. 1546-1554
-
-
Martin, G.S.1
Mannino, D.M.2
Eaton, S.3
-
2
-
-
0034958947
-
Epidemiology of severe sepsis in the United States: analysis of incidence,outcome,andassociated costs of care
-
Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence,outcome,andassociated costs of care. Crit Care Med 2001; 9: 1303-10.
-
(2001)
Crit Care Med
, vol.9
, pp. 1303-1310
-
-
Angus, D.C.1
Linde-Zwirble, W.T.2
Lidicker, J.3
-
3
-
-
84873339299
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012
-
Dellinger RP, Levy MM, Rhodes A et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.
-
(2013)
Crit Care Med
, vol.41
, pp. 580-637
-
-
Dellinger, R.P.1
Levy, M.M.2
Rhodes, A.3
-
4
-
-
84861665800
-
Drotrecogin a (activated) in adults with septic shock
-
Ranieri MC, Thompson BT, Barie PS et al. Drotrecogin a (activated) in adults with septic shock. N Engl J Med 2012; 366: 2055-64.
-
(2012)
N Engl J Med
, vol.366
, pp. 2055-2064
-
-
Ranieri, M.C.1
Thompson, B.T.2
Barie, P.S.3
-
5
-
-
58849166805
-
Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
-
Restrepo MI, Mortensen EM, Waterer GW et al. Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia. Eur Resp J 2009; 33: 1531-9.
-
(2009)
Eur Resp J
, vol.33
, pp. 1531-1539
-
-
Restrepo, M.I.1
Mortensen, E.M.2
Waterer, G.W.3
-
6
-
-
77951209165
-
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia
-
Martin-Loeches I, Lisboa T, Rodriguez A et al. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 2010; 36: 612-20.
-
(2010)
Intensive Care Med
, vol.36
, pp. 612-620
-
-
Martin-Loeches, I.1
Lisboa, T.2
Rodriguez, A.3
-
7
-
-
42549119145
-
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia
-
Giamarellos-Bourboulis EJ, Pechère JC, Routsi C et al. Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia. Clin Infect Dis 2008; 46: 1157-64.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 1157-1164
-
-
Giamarellos-Bourboulis, E.J.1
Pechère, J.C.2
Routsi, C.3
-
8
-
-
0037389094
-
2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference
-
Levy M, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit CareMed2003;31: 1250-6.
-
(2003)
Crit Care Med
, vol.31
, pp. 1250-1256
-
-
Levy, M.1
Fink, M.P.2
Marshall, J.C.3
-
9
-
-
0030900783
-
Fever in the clinical diagnosis of acute pyelonephritis
-
Pinson AG, Philbrick JT, Lindbeck GH et al. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997; 15: 148-51.
-
(1997)
Am J Emerg Med
, vol.15
, pp. 148-151
-
-
Pinson, A.G.1
Philbrick, J.T.2
Lindbeck, G.H.3
-
10
-
-
22144444944
-
The International Sepsis Forum Consensus definitions of infections in the intensive care unit
-
Calandra T, Cohen J. The International Sepsis Forum Consensus definitions of infections in the intensive care unit. Crit Care Med 2005; 33: 1639-48.
-
(2005)
Crit Care Med
, vol.33
, pp. 1639-1648
-
-
Calandra, T.1
Cohen, J.2
-
11
-
-
0037464808
-
Statistics notes interaction revisited: the difference between two estimates
-
Altman DG, Bland JM. Statistics notes interaction revisited: the difference between two estimates. Brit Med J 2003; 326: 219.
-
(2003)
Brit Med J
, vol.326
, pp. 219
-
-
Altman, D.G.1
Bland, J.M.2
-
12
-
-
81055145174
-
Nationwide trends of severe sepsis in the 21st century (2000-2007)
-
Kumar G, Kumar A, Tanela A et al. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011; 140: 1223-31.
-
(2011)
Chest
, vol.140
, pp. 1223-1231
-
-
Kumar, G.1
Kumar, A.2
Tanela, A.3
-
13
-
-
84862557241
-
Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study
-
Spyridaki A, Raftogiannis M, Antonopoulou A et al. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. Antimicrob Agents Chemother 2012; 56: 3819-25.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 3819-3825
-
-
Spyridaki, A.1
Raftogiannis, M.2
Antonopoulou, A.3
-
14
-
-
78651468128
-
Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia
-
Giamarellos-Bourboulis EJ, van de Veerdonk, Mouktaroudi M et al. Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia. Crit Care 2011; 15: R27.
-
(2011)
Crit Care
, vol.15
-
-
Giamarellos-Bourboulis, E.J.1
van de Veerdonk2
Mouktaroudi, M.3
-
15
-
-
84860581686
-
Macrolide antibiotics and survival in patients with acute lung injury
-
Walkey AJ, Wiener RS. Macrolide antibiotics and survival in patients with acute lung injury. Chest 2012; 141: 1153-9.
-
(2012)
Chest
, vol.141
, pp. 1153-1159
-
-
Walkey, A.J.1
Wiener, R.S.2
-
16
-
-
84863933351
-
Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis
-
Asadi L, Sligl WI, Eurich DT et al. Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2012; 55: 371-80.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 371-380
-
-
Asadi, L.1
Sligl, W.I.2
Eurich, D.T.3
-
17
-
-
0043237932
-
Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval
-
Iannini PB. Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval. Expert Opin Drug Saf 2002; 1: 121-8.
-
(2002)
Expert Opin Drug Saf
, vol.1
, pp. 121-128
-
-
Iannini, P.B.1
|